LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $24,095,572

Key CONT_AWD_75N91019F00138_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 109 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91019F00138_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91019F00138_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:44Z

Content hash 0ccb0f3f820101e6cb780feebc68572cf0a8b88ba383daa0f5a23e93f1176697

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$24,095,572	first version	September 20, 2019	May 19, 2026	2026-09-05T00:54:44Z	historical sweep	`0ccb0f3f8201`

Archived copy

https://web.archive.org/web/20261011092523/https://www.usaspending.gov/award/CONT_AWD_75N91019F00138_7529_75N91019D00024_7529 captured by this system, October 11, 2026

What the amount is made of

15 recorded actions, so the amount is the award's current total across all of them. 11 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $30,072,496.

Action date	Modification	Type	Obligated	Description as recorded
September 23, 2026	P00014	OTHER ADMINISTRATIVE ACTION	+$1,809,442	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
September 17, 2026	P00013	OTHER ADMINISTRATIVE ACTION	+$4,167,482	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
May 19, 2026	P00012	OTHER ADMINISTRATIVE ACTION	no money	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
September 17, 2025	P00011	OTHER ADMINISTRATIVE ACTION	+$2,478,621	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
August 26, 2025	P00010	OTHER ADMINISTRATIVE ACTION	+$2,014,484	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
May 2, 2025	P00009	OTHER ADMINISTRATIVE ACTION	no money	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
September 19, 2024	P00008	EXERCISE AN OPTION	+$5,077,161	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
July 18, 2024	P00007	OTHER ADMINISTRATIVE ACTION	no money	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
June 7, 2024	P00006	OTHER ADMINISTRATIVE ACTION	no money	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
September 11, 2023	P00005	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	+$1,777,461	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
June 28, 2022	P00004	FUNDING ONLY ACTION	+$1,284,221	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
May 18, 2022	P00003	OTHER ADMINISTRATIVE ACTION	+$414,862	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
May 27, 2021	P00002	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	+$7,268,296	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
March 5, 2021	P00001	FUNDING ONLY ACTION	+$218,703	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
September 20, 2019	base	not on file	+$3,561,763	CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS

Last refreshed November 4, 2026 at 2:31 PM UTC.